All articles tagged with #adverse effects
A recent study published in BMJ Evidence-Based Medicine found that tramadol, a commonly prescribed opioid for chronic pain, offers minimal pain relief and poses significant health risks, including serious cardiovascular events, leading experts to question its use for long-term pain management.
A recent systematic review suggests that tramadol provides minimal pain relief for chronic pain conditions while doubling the risk of serious side effects, mainly cardiac issues, leading experts to recommend reconsidering its use for such cases.
A research team alleges that Pfizer concealed two deaths during its COVID-19 vaccine clinical trials, potentially indicating dangerous side effects. The deaths, one in Kansas and another in Georgia, were not reported in a timely manner, raising concerns about the trial's integrity and the vaccine's safety. The researchers argue that these omissions could have influenced the vaccine's emergency use authorization and highlight potential cardiovascular risks associated with the vaccine. The findings suggest Pfizer may have been aware of these risks before the vaccine's approval.
The largest COVID-19 vaccine study involving nearly 100 million people across eight countries has found a link between the Pfizer, Moderna, and AstraZeneca vaccines and slight increases in neurological, blood, and heart-related conditions. While the study emphasizes that the association between the vaccines and adverse side effects does not prove causation, it prompts individuals to consider their medical condition and need for protection. Dr. Jonathan Kantor, an expert in clinical epidemiology, stresses that while vaccines have risks, their benefits still outweigh the potential risks, and the decision to get vaccinated should be based on individual circumstances.
A multi-country study of nearly 100 million vaccinated individuals found links between COVID-19 vaccines and increased risks for adverse effects such as myocarditis and Guillain-Barré syndrome. The study, conducted by the Global COVID Vaccine Safety project, looked at recipients of Pfizer, Moderna, and AstraZeneca vaccines across eight countries and identified higher-than-expected instances of certain adverse events. The researchers emphasized the importance of considering the risk associated with COVID-19 infection when evaluating the risk-to-benefit ratio of vaccination.
A study of nearly 100 million vaccinated individuals across eight countries found links between COVID-19 vaccines and increased risks for adverse effects such as myocarditis and Guillain-Barré syndrome. The study, conducted by the Global COVID Vaccine Safety project, specifically looked at adverse events following administration of Pfizer, Moderna, and AstraZeneca vaccines. While the study identified safety signals, it emphasized the rarity, severity, and clinical relevance of these adverse events and highlighted the importance of considering the overall risk-benefit evaluations of vaccination in the context of the risks associated with SARS-CoV-2 infection.
A peer-reviewed study published in Therapeutic Advances in Drug Safety found shocking rates of COVID-19 shot-induced myocarditis, especially in males between the ages of 0 and 30, with 3078 reports of COVID-19 vaccine-induced myocarditis, 76% resulting in emergency care and hospitalization, and 3% resulting in death. The study calls for further investigation into the underlying mechanisms of COVID-19 vaccine-induced myocarditis to ensure the safety of COVID-19 vaccination programs across populations.
A study conducted by researchers from Hanyang University Medical Center in South Korea reveals that teenagers who use smartphones for more than four hours a day are more likely to experience adverse mental health and substance use. The study analyzed data from over 50,000 Korean adolescents and found that excessive smartphone use was associated with higher rates of stress, suicidal thoughts, obesity, and substance use. Interestingly, those who used their phones for only one to two hours faced fewer issues than those who did not use their phones at all. The study highlights the need for guidelines regarding smartphone usage among teenagers.
A group of medical professionals, researchers, patient representatives, and politicians are urging the UK government to reverse the rate of antidepressant prescribing, which has nearly doubled in England over the past decade. They highlight the adverse effects and withdrawal symptoms associated with long-term use of antidepressants, as well as the lack of improvement in mental health outcomes at the population level. The group calls for public health recommendations to be implemented, including stopping the prescribing of antidepressants for mild conditions, adhering to safe prescribing and withdrawal management guidelines, and funding withdrawal services integrated with non-pharmacological interventions. They also suggest reducing antidepressant prescribing as an indicator in healthcare quality frameworks and establishing a national prescribed drug withdrawal helpline and website.
A Texas woman claims to have suffered severe burns and charred skin on her genitals, anus, and buttocks after taking the Type-2 diabetes medication Ozempic, which is known for its weight-shedding properties. The woman, who had been on the medication since April, experienced excruciating pain and discovered pieces of charred skin on her toilet seat. Other patients have reported adverse effects such as suicidal thoughts and stomach paralysis after taking Ozempic. The woman has filed a complaint with the company and reported the incident to the FDA. While the medication helped lower her blood sugar, she does not recommend its use due to the numerous adverse effects.
A 6-month-old baby boy's dark brown eyes turned bright blue after receiving the COVID-19 treatment favipiravir. The discoloration occurred 18 hours after starting the medication but faded after five days once the treatment was stopped. No damage to the child's vision was observed, and the exact cause of the eye color change is unknown. Favipiravir has been approved for COVID-19 treatment in several countries but has not received FDA approval.